Zhongnan Medical Journal Press

Home Results

A total of 6 result was found. Results that relate to ZHANG Wei

Evaluation of efficacy and safety of Sintilimab+Bevacizumab combined with PP regime in patients with advanced non-squamous non-small cell lung cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(1):93-99.
2642 times 799 times

SHEN Junjie JIN Jianwei RUAN Zekun ZHANG Weiping

Advanced non-squamous non-small lung cell cancer Sintilimab Bevacizumab Efficay Safety
Details
Status of etiology and pathogenesis of lumbar ligamentum flavum hypertrophy

Published on Journal of Mathematical Medicine 2024,37(7):534-542.
5046 times 1106 times

MAO Jianwei [MW ZHANG Weiping YANG Chen LI Jingzhou QIANG Tianming DUAN Wenshuai

Ligamentum flavum hypertrophy Fibrosis Etiology Pathogenesis
Details
Construction of a risk prediction model for 1-year readmission in patients undergoing percutaneous coronary intervention treated with bayaspirin combined with clopidogrel

Published on Frontiers in Pharmaceutical Sciences 2024,28(1):41-48.
4220 times 695 times

LYU Yuan CHEN Peipei WU Qiongbi ZHANG Wei

Myocardial infarction Percutaneous coronary intervention Readmission Predictive model Bayaspirin Clopidogrel
Details
Research progress on the therapeutic effect and mechanism of Xiaoxuming decoction on nervous system diseases

Published on Frontiers in Pharmaceutical Sciences 2024,28(3):536-549.
4390 times 655 times

LIU Xuan HOU Huiling SONG Weipeng LI Xiaoming LIU Yang ZHANG Wei ZHANG Xiwu ZHAO Weiming

Xiaoxuming decoction Nervous system disease Stroke Facial nerve paralysis Vertigo Alzheimer's disease Oxidative stress Autophagy Ferroptosis
Details
Quality evaluation of Xinmai'an tablets based on fingerprint and multi-component determination

Published on Frontiers in Pharmaceutical Sciences 2025,29(3):406-415.
1859 times 452 times

WU Shuangfeng ZHANG Wei SUN Xiaobo WANG Deqin GUO Haibiao LIU Xiaoqiu

Xinmai'an tablets High performance liquid chromatography Fingerprint Chemometrics Content determination Paeoniflorin Calycosin-7-O-β-D-glucoside Salvianolic acid B Cryptotanshinone Tanshinone Ⅰ Tanshinone ⅡA
Details
Optimization of inclusion process for Ramulus cinnamomi volatile oil using Plackett-Burman design combined with Box-Behnken response surface methodology

Published on Frontiers in Pharmaceutical Sciences 2025,29(7):1108-1118.
842 times 112 times

JIANG Mingyue QI Shuang CAO Jixiang LIU Zhenyuan WU Tianqi WANG Changqi BAI Xue HAN Pei ZHANG Wei

Ramulus cinnamomi volatile oil Inclusion process Plackett-Burman Box-Behnken response surface analysis
Details